MCM
KURA icon

MAI Capital Management’s Kura Oncology KURA Stock Holding History

MAI Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
13,222
+8,574
+184% +$80.9K ﹤0.01% 1868
2026
Q1 		$37.8K Buy
4,648
+1,522
+49% +$13.1K ﹤0.01% 2417
2025
Q4 		$32.5K Buy
3,126
+36
+1% +$378 ﹤0.01% 2256
2025
Q3 		$27.3K Hold
3,090
– – ﹤0.01% 2263
2025
Q2 		$17.8K Buy
3,090
+90
+3% +$551 ﹤0.01% 2399
2025
Q1 		$19.8K Hold
3,000
– – ﹤0.01% 2184
2024
Q4 		$26.1K Buy
+3,000
New +$43.2K ﹤0.01% 2094

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

MAI Capital Management's KURA Position: Q2 2026 in Review

MAI Capital Management increased its Kura Oncology (KURA) stake by 184% in Q2 2026, buying an estimated $80.9K and bringing the position to 13,222 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #1868.

MAI Capital Management first reported a position in KURA in Q4 2024 and has held it in 7 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • MAI Capital Management held 13,222 shares of Kura Oncology worth $145K as of Q2 2026.
  • MAI Capital Management bought 8,574 Kura Oncology shares in Q2 2026, an estimated $80.9K.
  • Kura Oncology made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1868 holding.
  • MAI Capital Management first reported a position in Kura Oncology in Q4 2024 and has held it in 7 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.